Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Networking for ovarian rare tumors: a significant breakthrough improving disease management.
Chiannilkulchai N, Pautier P, Genestie C, Bats AS, Vacher-Lavenu MC, Devouassoux-Shisheboran M, Treilleux I, Floquet A, Croce S, Ferron G, Mery E, Pomel C, Penault-Llorca F, Lefeuvre-Plesse C, Henno S, Leblanc E, Lemaire AS, Averous G, Kurtz JE, Ray-Coquard I. Chiannilkulchai N, et al. Among authors: genestie c. Ann Oncol. 2017 Jun 1;28(6):1274-1279. doi: 10.1093/annonc/mdx099. Ann Oncol. 2017. PMID: 28398524 Free article.
Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework.
Maury P, Mondini M, Chargari C, Darricau A, Shahin M, Ammari S, Bockel S, Genestie C, Wu TD, Lux F, Tillement O, Lacombe S, Deutsch E, Robert C, Porcel E. Maury P, et al. Among authors: genestie c. Nanomedicine. 2023 Jun;50:102676. doi: 10.1016/j.nano.2023.102676. Epub 2023 Apr 20. Nanomedicine. 2023. PMID: 37084803
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Vermij L, Jobsen JJ, León-Castillo A, Brinkhuis M, Roothaan S, Powell ME, de Boer SM, Khaw P, Mileshkin LR, Fyles A, Leary A, Genestie C, Jürgenliemk-Schulz IM, Crosbie EJ, Mackay HJ, Nijman HW, Nout RA, Smit VTHBM, Creutzberg CL, Horeweg N, Bosse T; TransPORTEC Consortium. Vermij L, et al. Among authors: genestie c. Br J Cancer. 2023 Mar;128(7):1360-1368. doi: 10.1038/s41416-023-02141-0. Epub 2023 Jan 23. Br J Cancer. 2023. PMID: 36690721 Free PMC article.
Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.
Pautier P, Genestie C, Fizazi K, Morice P, Mottet C, Haie-Meder C, Le Cesne A, Lhommé C. Pautier P, et al. Among authors: genestie c. Int J Gynecol Cancer. 2002 Nov-Dec;12(6):749-54. doi: 10.1046/j.1525-1438.2002.01144.x. Int J Gynecol Cancer. 2002. PMID: 12445254
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ].
Querleu D, Bonnier P, Morice P, Narducci F, Lhomme C, Haie-Meder C, Aubard Y, Baldauf JJ, Barillot I, Castelain B, Cuisenier J, Duvillard P, Genestie C, Houvenaeghel G, Leblanc E, Lefranc JP, Lejeune C, Mathevet P, Pautier P, Romestaing P, Tubiana N, Villet R; Société Française d'Oncologie Gynécologique. Querleu D, et al. Among authors: genestie c. Gynecol Obstet Fertil. 2008 Mar;36(3):338-52. doi: 10.1016/j.gyobfe.2008.01.008. Gynecol Obstet Fertil. 2008. PMID: 18494150 French. No abstract available.
Pathology of endometrioid carcinoma.
Albertini AF, Devouassoux-Shisheboran M, Genestie C. Albertini AF, et al. Among authors: genestie c. Bull Cancer. 2012 Jan;99(1):7-12. doi: 10.1684/bdc.2011.1526. Bull Cancer. 2012. PMID: 22231875 Free article. Review.
[Gynecopathology. Case 5. Epithelioid smooth muscle tumors].
Genestie C, Devouassoux-Shisheboran M. Genestie C, et al. Ann Pathol. 2012 Jun;32(3):202-5. doi: 10.1016/j.annpat.2012.04.005. Epub 2012 Jun 8. Ann Pathol. 2012. PMID: 22748337 French. No abstract available.
155 results